Surviving chemotherapy for colon cancer and living with the consequences
- PMID: 21091028
- DOI: 10.1089/jpm.2010.0124
Surviving chemotherapy for colon cancer and living with the consequences
Abstract
Background: This article discusses peripheral neuropathy as a long-term side effect of oxaliplatin based chemotherapy, from a colon cancer survivor's perspective. Peripheral neuropathy is a common side effect of chemotherapy that affects quality of life for many cancer survivors. Severe and debilitating neuropathy negatively impacts both physical and emotional well-being.
Discussion: A better understanding of what cancer survivors with peripheral neuropathy experience is essential for health care professionals. More emphasis on symptom management and development of evidence based interventions will help improve quality of life for those who are affected by chemotherapy induced peripheral neuropathy.
Similar articles
-
Oxaliplatin in the adjuvant treatment of colon cancer.CA Cancer J Clin. 2012 Jan-Feb;62(1):3-4. doi: 10.3322/caac.21131. Epub 2011 Nov 16. CA Cancer J Clin. 2012. PMID: 22095255 No abstract available.
-
The effect of diabetes on oxaliplatin-induced peripheral neuropathy.Clin Colorectal Cancer. 2012 Dec;11(4):275-9. doi: 10.1016/j.clcc.2012.05.002. Epub 2012 Jun 7. Clin Colorectal Cancer. 2012. PMID: 22682776
-
Challenges Evaluating Chemotherapy-Induced Peripheral Neuropathy in Childhood Cancer Survivors.J Pediatr Oncol Nurs. 2017 Mar/Apr;34(2):106-114. doi: 10.1177/1043454216651016. Epub 2016 Jul 7. J Pediatr Oncol Nurs. 2017. PMID: 27251891 Review.
-
Oxaliplatin shows significant benefit over standard therapy in early-stage colon cancer.Oncology (Williston Park). 2004 Sep;18(10):1313. Oncology (Williston Park). 2004. PMID: 15526833 No abstract available.
-
An overview of chemotherapy-induced peripheral sensory neuropathy, focusing on oxaliplatin.Int J Palliat Nurs. 2001 Jul;7(7):354-9. doi: 10.12968/ijpn.2001.7.7.9020. Int J Palliat Nurs. 2001. PMID: 11951404 Review.
Cited by
-
Antineuropathic profile of N-palmitoylethanolamine in a rat model of oxaliplatin-induced neurotoxicity.PLoS One. 2015 Jun 3;10(6):e0128080. doi: 10.1371/journal.pone.0128080. eCollection 2015. PLoS One. 2015. PMID: 26039098 Free PMC article.
-
Increases in adipose tissue and muscle function are longitudinally associated with better quality of life in colorectal cancer survivors.Sci Rep. 2021 Jun 14;11(1):12440. doi: 10.1038/s41598-021-91709-y. Sci Rep. 2021. PMID: 34127719 Free PMC article.
-
Characterization of Novel α-Mangostin and Paeonol Derivatives With Cancer-Selective Cytotoxicity.Mol Cancer Ther. 2022 Feb;21(2):257-270. doi: 10.1158/1535-7163.MCT-20-0787. Epub 2021 Nov 17. Mol Cancer Ther. 2022. PMID: 34789561 Free PMC article.
-
Impact of oxaliplatin-induced neuropathy: a patient perspective.Support Care Cancer. 2012 Nov;20(11):2959-67. doi: 10.1007/s00520-012-1428-5. Epub 2012 Mar 17. Support Care Cancer. 2012. PMID: 22426503
-
Efficacy and tolerability of controlled-release oxycodone for oxaliplatin-induced peripheral neuropathy and the extension of FOLFOX therapy in advanced colorectal cancer patients.Support Care Cancer. 2014 Jun;22(6):1579-84. doi: 10.1007/s00520-014-2132-4. Epub 2014 Jan 24. Support Care Cancer. 2014. PMID: 24452412 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
